Geron (GERN) Operating Expenses (2010 - 2026)
Geron's (GERN) quarterly Operating Expenses came in at $1.7 million in Q1 2026, up 40.3% year-on-year from $1.2 million in Q1 2025, and up 100.97% quarter-over-quarter from -$174.2 million in Q4 2025.
Geron (GERN) Operating Expenses (2010 - 2026) Analysis & Trends
Geron has disclosed Operating Expenses across 17 years of filings, most recently posting $1.7 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $1.7 million, up 40.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$109.9 million (down 143.64% YoY), and the FY2025 annual result was $4.7 million, down 98.11% from the prior year.
- Operating Expenses came in at $1.7 million for Q1 2026 at Geron, up from -$174.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $250.3 million in Q4 2024 to a low of -$174.2 million in Q4 2025.
- The 5-year median for Operating Expenses is $34.5 million (2022), against an average of $29.7 million.
- Peak annual rise in Operating Expenses reached 361605.88% in 2025, while the deepest fall reached 169.6% in 2025.
- Geron's Operating Expenses stood at $42.1 million in 2022, then increased by 29.15% to $54.3 million in 2023, then soared by 360.77% to $250.3 million in 2024, then tumbled by 169.6% to -$174.2 million in 2025, then surged by 100.97% to $1.7 million in 2026.
- The last three Operating Expenses figures came in at $1.7 million (Q1 2026), -$174.2 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -67.40 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | -174.17 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 61.49 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 250.25 Mn |
| Sep 30, 2024 | 456,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Dec 31, 2023 | 54.31 Mn |
| Sep 30, 2023 | 47.78 Mn |
| Jun 30, 2023 | 51.98 Mn |
| Mar 31, 2023 | 40.11 Mn |
| Dec 31, 2022 | 42.05 Mn |
| Sep 30, 2022 | 40.25 Mn |
| Jun 30, 2022 | 28.05 Mn |
| Mar 31, 2022 | 28.80 Mn |
| Dec 31, 2021 | 32.02 Mn |
| Sep 30, 2021 | 25.78 Mn |
| Jun 30, 2021 | 29.00 Mn |
| Mar 31, 2021 | 28.59 Mn |